【诺和诺德(NVO.US)终止Hims & Hers(HIMS.US)合作 转投WeightWatchers(WGHTQ.US)销售Wegovy】智通财经APP获悉,诺和诺德(NVO.US)近日与WeightWatchers(WGHTQ.US)达成合作协议销售其减肥药Wegovy。此前,这家丹麦制药巨头刚终止了与远程医疗公司Hims
& Hers Health(HIMS.US)的类似合作,该协议原本允许后者直接销售这款GLP-1受体激动剂明星药物。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.